Targeting thrombin – rational drug design from natural mechanisms
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (11) , 589-595
- https://doi.org/10.1016/j.tips.2003.09.002
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Protease activated receptors 1 and 4 govern the responses of human platelets to thrombinTransfusion and Apheresis Science, 2003
- The Molecular Basis of Thrombin Allostery Revealed by a 1.8 Å Structure of the “Slow” FormStructure, 2003
- Molecular mapping of thrombin‐receptor interactionsProteins-Structure Function and Bioinformatics, 2001
- Identification of Critical Residues on Thrombin Mediating Its Interaction with FibrinThrombosis and Haemostasis, 2001
- Structure of the Ser195Ala mutant of human α-thrombin complexed with fibrinopeptide A(7–16): evidence for residual catalytic activityActa Crystallographica Section D-Biological Crystallography, 2000
- Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complexNature, 2000
- Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor IIJournal of Biological Chemistry, 1999
- Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surfaceThe FASEB Journal, 1995
- The clot thickens: clues provided by thrombin structureTrends in Biochemical Sciences, 1995
- Molecular mapping of the heparin-binding exosite of thrombin.Proceedings of the National Academy of Sciences, 1994